You searched for Leukemia.
Page 2 of 85 results
Oncology Clinical Trial: Study of Blood Samples From Newborns With Down Syndrome
Clinical Trial Protocol # AAML08B1 | Biology/Genomics, Leukemia/Lymphoma | Contact (714) 509-8646
ADVL1721/COG/Bayer 806946/19176: A non-randomized, open-label, multi-center, Phase I/II study of PI3K inhibitor copanlisib in pediatric patients with relapsed/refractory solid tumors or lymphoma
Clinical Trial Protocol # ADVL1721 | Adolescents and Young Adults, Leukemia/Lymphoma, Recurrent/Refractory Cancer, Solid Tumors | Contact (714) 509-8646
Oncology Clinical Trial: Study of Kidney Tumors in Younger Patients
Clinical Trial Protocol # AREN03B2 | Biology/Genomics, Registry | Contact (714) 509-8646
Oncology Clinical Trial: Brentuximab Vedotin and Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed Hodgkin Lymphoma
Clinical Trial Protocol # AHOD1331 | Adolescents and Young Adults, Leukemia/Lymphoma | Contact (714) 509-8646
Oncology Clinical Trial: Molecular Profiles of Refractory and Recurrent Childhood, Adolescent, and Young Adult Cancers
Clinical Trial | Adolescents and Young Adults, Biology/Genomics, Brain Tumor/Central Nervous System/Neuro-Oncology, Leukemia/Lymphoma, Recurrent/Refractory Cancer, Solid Tumors | Contact (714) 509-8646
Oncology Clinical Trial: Brentuximab Vedotin or Crizotinib and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II-IV Anaplastic Large Cell Lymphoma
Clinical Trial Protocol # ANHL12P1 | Leukemia/Lymphoma | Contact (714) 509-8646
Phase 1/2 Study of Lenvatinib in Combination with Everolimus in Recurrent and Refractory Pediatric Solid Tumors, including CNS
Clinical Trial Protocol # ADVL1711 | Adolescents and Young Adults, Recurrent/Refractory Cancer, Solid Tumors | Contact (714) 509-8646
Phase 1 Study of Pevonedistat (MLN4924, IND# 136078), a NEDD8 Activating Enzyme (NAE) Inhibitor, in Combination with Temozolomide and Irinotecan in Pediatric Patients with Recurrent or Refractory Solid Tumors
Clinical Trial Protocol # ADVL1615 | Adolescents and Young Adults, Recurrent/Refractory Cancer, Solid Tumors | Contact (714) 509-8646
Phase 1 Study of ABI-009 (nab-rapamycin) in Pediatric Patients with Recurrent or Refractory Solid Tumors, including CNS Tumors as a Single Agent and in Combination with Temozolomide and Irinotecan
Clinical Trial Protocol # ADVL1514 | Adolescents and Young Adults, Recurrent/Refractory Cancer, Solid Tumors | Contact (714) 509-8646
Phase 1/2 Study of VX15/2503 (IND# 136181) in Children, Adolescents, or Young Adults with Recurrent or Relapsed Solid Tumors
Clinical Trial Protocol # ADVL1614 | Adolescents and Young Adults, Recurrent/Refractory Cancer, Solid Tumors | Contact (714) 509-8646
Phase 2 Trial of XL184 (Cabozantinib) an Oral Small-Molecule Inhibitor of Multiple Kinases, in Children and Young Adults with Refractory Sarcomas, Wilms Tumor, and Other Rare Tumors
Clinical Trial Protocol # ADVL1622 | Adolescents and Young Adults, Recurrent/Refractory Cancer, Solid Tumors | Contact (714) 509-8646
Breaking Barriers in Acute Lymphoblasic Luekemia (ALL)
This year, the conference, titled "Breaking Barriers in Acute Lymphoblastic Leukemia," focused, as the name implies, specifically on all aspects of acute lymphoblastic leukemia (ALL).
Young cancer patients take a break from the battle at ‘Oncology Ball’
Some dressed up in suits and gowns. Some were on crutches. Some pulled electronic carts attached to IV lines dangling from their bodies.All were eager to attend the 18th annual Oncology Ball at Children’s Hospital of Orange County in Orange.
Ducks Players Bring Joy, Boost Spirits in Annual Visit to CHOC Children’s
Caedmon Blake could never have imagined his day at CHOC Children's last week would bring him face to face with some hockey heroes from his favorite sport.
Parent Advice Line
To use PAL, simply call (714) 912-8927, enter the four-digit topic numbers listed on this web page, or stay on the line for a complete listing of topics.
RDs In Practice: Nutritional Management of Pediatric Oncology
This program is intended for pediatric registered dietitians and clinicians who specialize in oncology.
I Am a Cancer Researcher
In October of this past year, I attended the second annual Society of Adolescent and Young Adult Oncology (SAYAO) conference: Breaking Barriers in Acute Lymphoblastic Leukemia. The conference marked the launch of a new campaign called "I am a cancer researcher."
Huynh, Van T. MD
Dr. Huynh is a pediatric oncologist who specializes in acute leukemia. She is board certified in both general pediatrics and pediatric hematology/oncology.
Pediatric Hematology/Oncology Fellowship Program
This program is a 3 year ACGME-accredited program encompassing a clinical year followed by two years of basic, translational and clinical research.
Invited Speakers
Invitation Only - 2018 Leukemia Think-Tank - From Pediatric to Adult Acute Lymphoblastic Leukemia: The Age of Cellular Therapy, Nov. 5-6, 2018
Oncology Clinical Trial: Blood Sample Markers of Reproductive Hormones in Assessing Ovarian Reserve in Younger Patients With Newly Diagnosed Lymphomas
Clinical Trial Protocol # ALTE11C1 | Adolescents and Young Adults, Fertility, Survivorship | Contact (714) 509-8646
Blood and Marrow Transplant Program
Our program is the only pediatric blood and marrow transplant program in Orange County and offers a full range of transplant procedures and services for cancer patients.
Cancer Resources for Caregivers
Find camps and activities for cancer patients, as well as information on scholarships, support and guidance for teens and young adults that may be helpful for families as they undergo treatment.
Active treatment
Regular exercise may help mitigate the lingering psychological impact of childhood cancer.
Children’s hospital throws socially distanced prom for cancer patients
A look inside the 19th annual CHOC Children’s Oncology Ball presented by The J. Willard and Alice S. Marriott Foundation.
